National Association of Boards of Pharmacy

From Wikipedia, the free encyclopedia
(Redirected from Board of Pharmacy)

The 'National Association of Boards of Pharmacy.[1] The NABP membership is composed of 54 active members and 12 associate members. Active member boards include all 50 United States, the District of Columbia, Guam, Puerto Rico, and the Virgin Islands. Associate member boards are The Bahamas, and 10 Canadian provinces.[1] Australia was formerly an associate member but was removed in 2020.[2]

NABP supports its member boards of pharmacy by offering:[3]

  • Examinations that assess pharmacists’ competency to practice pharmacy. These examinations include the North American Pharmacist Licensure Examination (NAPLEX) and the Multistate Pharmacy Jurisprudence Examination (MPJE).
  • License transfer program that alleviates the administrative burden on boards by verifying pharmacists’ applications for license transfer,
  • Accreditation programs that create uniform standards and perform inspections to supplement board staff and alleviate financial burden.
  • Many other services that provide pertinent resources to assist the boards of pharmacy as they work to protect the public health each day.

History[edit]

The NABP originated in the United States in 1904.[4]

In 1999, the NABP developed the Verified Internet Pharmacy Practice Sites (VIPPS) program to accredit online pharmacies.

In 2004, the NABP developed the Verified-Accredited Wholesale Distributors (VAWD) program to accredit Wholesale Distributors and to help protect the public from the threat of counterfeit drugs.[5]

In 2011, the NABP implemented a data exchange that allows authorized pharmacists, law enforcement agents, and regulatory boards to access patient-specific controlled substance prescription information. Known as NABP PMP InterConnect®, the platform provides a single page summary of patient's drug seeking activities across state lines. As of 2018, authorized users in 42 states have accessed data using the system in order to prevent drug abuse and drug diversion.[6]

Top-level domain .pharmacy[edit]

In 2014, the NABP launched the generic top-level domain (gTLD) .pharmacy, "to provide consumers around the world a means for identifying safe, legal, and ethical online pharmacies and related resources".[7]

The impartiality of the domain has been questioned, because Eli Lilly and Company, Merck & Co., and Pfizer are the main contributors to the NABP application. Previously, that application was challenged by Public Citizen, Knowledge Ecology International, and the Canadian International Pharmacy Association.[8]

References[edit]

  1. ^ a b "About". National Association of Boards of Pharmacy. Retrieved January 17, 2018.
  2. ^ "Issues Regarding and Suggestions For Dividing The EC's Proposed Amendments To The NABP Constitution And Bylaws" (PDF). Retrieved 11 October 2020.
  3. ^ "NABP and the Boards of Pharmacy | National Association of Boards of Pharmacy". National Association of Boards of Pharmacy. Retrieved 2018-01-17.
  4. ^ Sonnedecker, Glenn; Kremers, Edward (1976). Kremers and Urdang's History of Pharmacy (4th ed.). American Institute of the History of Pharmacy. p. 218. ISBN 0931292174. Retrieved 9 May 2017.
  5. ^ Background of the VAWD. Retrieved from http://www.nabp.net/vawd/VAWDbackground.pdf.
  6. ^ "PMP InterConnect". NABP website. January 17, 2018. Retrieved January 17, 2018.
  7. ^ "NABP Launches .Pharmacy Generic Top-Level Domain to Help Consumers Find Safe Pharmacies Online" (Press release). National Association of Boards of Pharmacy. September 9, 2014. Retrieved November 7, 2018.
  8. ^ Can The Dot Pharmacy New Generic Domain Be Impartial?—Intellectual Property Watch (July 7, 2014)


Stub icon

This pharmacy-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=National_Association_of_Boards_of_Pharmacy&oldid=1182789356"